Compare AbbVie Inc (ABBV) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbbVie Inc vs Star Bulk Carriers Corp — how do they compare? AbbVie Inc trades at $248.98 (market cap $441.94B), while Star Bulk Carriers Corp trades at $27.66 (market cap $3.09B). The key difference: AbbVie Inc is far larger — about 143× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays the higher dividend (6.79%). Which is the better fit depends on your goals.
| ABBV | SBLK | |
|---|---|---|
Market Cap | $441.94B | $3.09B |
Sector | Health | Industrials |
52-Week High | $263.58 | $29.15 |
52-Week Low | $197.38 | $16.79 |
Enterprise Value | $506.19B | $3.77B |
Dividend Yield | 2.77% | 6.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABBV trades at $247.91, up 0.76% today, with a bullish technical signal supported by moving averages and oversold RSI levels. The company reported Q2 2026 EPS of $3.65, beating expectations, and maintains strong profitability with a 71.48% gross margin. Recent news highlights positive Phase 2 data for ELAHERE in ovarian cancer, reinforcing growth prospects beyond Humira's patent expiry.
Outlook is positive with analyst consensus target of $278.69, though high P/E of 70.05 and debt levels pose valuation and financial risks. Revenue growth driven by Skyrizi and Rinvoq offsets competitive pressures, but patent cliffs in the 2030s require monitoring. The stock offers dividend appeal with a $1.73 payout scheduled for August 2026.
Star Bulk Carriers (SBLK) trades at $28.90, up 1.08% on the day, with a bullish technical outlook supported by moving averages. The company reported strong Q2 2026 results, beating EPS estimates with $1.21 per share, and declared a $0.90 dividend. Fundamentals show robust profitability with a net income margin of 23.87% and a P/E ratio of 11.15, indicating potential value. Recent news highlights the termination of a vessel sale agreement with Diana Shipping, though the impact appears neutral.
The outlook for SBLK is positive, driven by strong earnings growth, healthy cash flow, and a favorable analyst consensus with 58.34% buy ratings. Key opportunities include high dividend yields and operational efficiency, while risks involve dry bulk rate volatility and competitive pressures in the shipping sector. Investors should weigh the company's solid financials against industry cyclicality.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
